[10] [11] Clinicians often assess baseline retinopathy status before initiating GLP-1 therapy in high-risk individuals
But in some cases, it may cause side effects such as pain or redness at the injection site, sensitivity, or changes in iron levels
Only authorised medicinal products are subject to regulatory control by competent authorities with regard to composition, quality, safety and efficacy
Symptom log: four-week daily entries with severity ratings
The study reports that markers such as high cholesterol and elevated blood pressure tend to worsen again after medication use ends
Patients were treated with exenatide (14/23) or liraglutide (9/23) and GLP-1 RAs treatment was again connected to a wide range of weight loss, from 1.5 to 16 kg/m 2 in 10/14 cases, and an HbA1c improvement in 19/23 cases, without reported serious side effects (36)